Tag: Precision oncology
TruSight Oncology 500 DNA/RNA Application: Accelerating Oncology Research
Beckman Coulter Life Sciences, in collaboration with Illumina, has introduced a new method for accelerating oncology research. The Illumina TruSight™ Oncology 500 DNA/RNA assay, utilized on the Biomek NGeniuS System, offers a streamlined and...
Illumina Oncology Menu for NovaSeq X Series: What You Need to Know
Illumina Inc. has recently expanded its oncology menu for NovaSeq X Series customers, delivering their flagship oncology products on their most powerful sequencers to enable comprehensive genomic profiling at greater scale and lower costs....
Advancing GIST Drug: IDRx Secures $120 Million Funding
IDRx, a precision oncology company based in the US, recently announced the successful completion of a $120 million series B preferred stock financing round. This funding was oversubscribed and led by RA Capital Management,...